Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02BTV
|
||||
| Former ID |
DNC003607
|
||||
| Drug Name |
3-Benzenesulfinyl-heptanoic acid hydroxyamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [525813] | ||
| Formula |
C13H19NO3S
|
||||
| Canonical SMILES |
CCCCC(CC(=O)NO)S(=O)C1=CC=CC=C1
|
||||
| InChI |
1S/C13H19NO3S/c1-2-3-7-12(10-13(15)14-16)18(17)11-8-5-4-6-9-11/h4-6,8-9,12,16H,2-3,7,10H2,1H3,(H,14,15)
|
||||
| InChIKey |
SQIUCETXNXHTSW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Interstitial collagenase | Target Info | Inhibitor | [525813] | |
| PANTHER Pathway | Alzheimer disease-presenilin pathway | ||||
| Plasminogen activating cascade | |||||
| WikiPathways | TGF beta Signaling Pathway | ||||
| Bladder Cancer | |||||
| Activation of Matrix Metalloproteinases | |||||
| Degradation of collagen | |||||
| Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||||
| Oncostatin M Signaling Pathway | |||||
| Prostate Cancer | |||||
| Integrated Breast Cancer Pathway | |||||
| Integrated Cancer pathway | |||||
| Cell surface interactions at the vascular wall | |||||
| Matrix Metalloproteinases | |||||
| References | |||||